Related Experiment Video
Updated: Dec 1, 2025

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226
Published on: May 10, 2022
Treg-dependent immunosuppression triggers effector T cell dysfunction via the STING/ILC2 axis
Kalliopi Domvri1, Savvas Petanidis2, Paul Zarogoulidis3
1Pulmonary Department-Oncology Unit, "G. Papanikolaou" General Hospital, Aristotle University of Thessaloniki, Thessaloniki 57010, Greece.
Abstract:
Lung cancer remains the leading cause of cancer-related deaths and despite extensive research, the survival rate of lung cancer patients remains significantly low. Recent data reveal that aberrant Kras signaling drives regulatory T cells (Tregs) present in lung tumor microenvironment to establish immune deregulation and immunosuppression but the exact pathogenic mechanism is still unknown. In this study, we investigate the role of oncogenic Kras in Treg-related immunosuppression and its involvement in tumor-associated metabolic reprogramming. Findings reveal Tregs to prompt GATA3/NOS2-related immunosuppression via STING inhibition which triggers a decline in CD4+ T infiltration, and a subsequent increase in lung metastatic burden. Enhanced Treg expression was also associated with low T/MDSC ratio through restriction of CD8+CD44+CD62L- T effector cells, contributing to a tumor-promoting status. Specifically, TIM3+/LAG3+ Tregs prompted Kras-related immunosuppressive chemoresistance and were associated with T cell dysfunction. This Treg-dependent immunosuppression correlated with CD8 T cell exhaustion phenotype and ILC2 augmentation in mice. Moreover, enhanced Treg expression promoted activation-induced cell death (AICD) of T lymphocytes and guided lymph node metastasis in vivo. Overall, these findings demonstrate the multifaceted roles of Tregs in sustaining lung immunosuppressive neoplasia through tumor microenvironment remodeling and provide new opportunities for effective metastasis inhibition, especially in chemoresistant tumors.
Insights
Oncogenic Kras signaling drives regulatory T cells (Tregs) to suppress the immune response in lung cancer, increasing metastasis. Targeting Tregs offers new strategies for inhibiting lung cancer spread, particularly in chemoresistant cases.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Lung cancer is a leading cause of cancer death with low survival rates.
- Aberrant Kras signaling in the lung tumor microenvironment drives regulatory T cells (Tregs), causing immune deregulation and immunosuppression.
- The precise pathogenic mechanisms linking Kras, Tregs, and lung cancer progression are not fully understood.
Purpose of the Study:
- To investigate the role of oncogenic Kras in Treg-mediated immunosuppression within the lung tumor microenvironment.
- To explore the involvement of Tregs in tumor-associated metabolic reprogramming in lung cancer.
- To elucidate the mechanisms by which Tregs contribute to lung cancer progression and metastasis.
Main Methods:
- Investigated the impact of oncogenic Kras on Treg function in the lung tumor microenvironment.
- Analyzed Treg-associated immunosuppressive pathways, including GATA3/NOS2 and STING inhibition.
- Assessed the effects of Treg expression on T cell infiltration, effector cell function, and tumor metastasis in vivo.
- Examined the correlation between Treg phenotypes (TIM3+/LAG3+) and chemoresistance, T cell dysfunction, and CD8 T cell exhaustion.
Main Results:
- Oncogenic Kras signaling promotes Treg-mediated immunosuppression via GATA3/NOS2 and STING inhibition, reducing CD4+ T cell infiltration and increasing lung metastasis.
- Enhanced Treg expression is linked to a low T/MDSC ratio and restricted CD8+ T effector cells, fostering a tumor-promoting environment.
- TIM3+/LAG3+ Tregs contribute to Kras-driven chemoresistance and T cell dysfunction, correlating with CD8 T cell exhaustion and ILC2 augmentation.
- Increased Treg activity promotes T lymphocyte activation-induced cell death (AICD) and facilitates lymph node metastasis.
Conclusions:
- Tregs play multifaceted roles in sustaining lung immunosuppressive neoplasia by remodeling the tumor microenvironment.
- Findings reveal novel Treg-dependent mechanisms driving lung cancer progression, immune evasion, and metastasis.
- Targeting Treg-mediated immunosuppression presents a promising therapeutic strategy for inhibiting metastasis, especially in chemoresistant lung tumors.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

